Genentech, Inc.

7 Active Projects

Title Investigator Start End
BA phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of etrolizumab as an induction and maintenance treatment for patients with moderately to severely active Crohn's disease Heyman
A Phase Ii Multi-Center, Randomized, Doubleblind, 24-Week, 3-Arm, Parallel Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of Ro5285119 In Children And Adolescents Age 5-17 With Autism Spectrum Disorder Hendren
An Observational Cohort Study of Treatment Patterns and Outcomes in Patients with Her2 Positive (Her2+) Metastatic Breast Cancer Rugo
An Open-Label Study To Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Relapsing Remitting Multiple Sclerosis Who Have Had A Suboptimal Response to an Adequate Course of Disease Modifying Treatment Waubant
CC# 16552 A Phase Ib, Open-Label Study Of The Safety And Tolerability Of Atezolizumab In Combination With Radium-223 Dichloride In Patients With Castrate-Resistant Prostate Cancer Who Have Progressed Following Treatment With An Androgen Pathway Inhib Fong
Phase III multicenter multicenter, randomized, double-blind, placebo controlled, parallel group efficacy and safety study of Crenezumbab in patients with propromal to mild Alzheimers disease Boxer
Juniper: An Open-Label Extension and Safety Monitoring Study of Patients with Moderately to Severely Active Crohn's disease Previously Enrolled in the Etrolizumab Phase III protocol GA29144 Heyman

24 Archived Projects

Title Investigator Start End
Phase II Double Blinded, Placebo-Controlled, Efficacy and Safety Evaluation of Allergen Immunotherapy Co-Administered with Omalizumab, an Anti-IgE mAb Bluestone
Task Order Number #2 - Development Criswell
Clinical Research Fellowship for Nisha Acharya Acharya
Effect of Ranibizumab on Refractory Macular Edema in Uveitis Phase I/II Acharya
Identification of Viruses in an Asthma Cohort Chiu
Characterizing the Rheological Properties of Cystic Fibrosis Sputum and the Effects of Mucoactive Agents. Fahy
Airway Microbiome in Severe Asthma Boushey
Adjuvant Treatment with Temodar plus Avastin Alone or with Tarceva in Patient with Newly Diagnosed Glioblastoma Multiforme Who Are Stable Following Radiotherapy with Temodar Prados
Phase 1b, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of MEGF0444A, A Humanized 1gG1 Antibody in Combination with Bevacizumab with or without Paclitaxel in Patients with Locally Advanced or Metastatic Solid Tumors Munster
A Pilot Study of FOLFOX in Combination with Bevacizumab in Patients with Advanced Neuroendocrine Tumors Bergsland
UCSF-Genentech Asthma Collaboration Task Order Burchard
IPF-2 Study Wolters
Phase II Study to Evaluate the Efficacy and Safety of MABT5102A in Patients with Mild to Moderate Alzheimer's Diseases Boxer
Harvesting of S. Mansoni schistosoma eggs McKerrow
Extension of Phase II Studies ABE4869g and ABE4955g in Patients with Mild to Moderate Alzheimer Disease Boxer
An Open-Label, Multicenter Extension Study of Trastuzumab-MCC-DM1 in Patients Previously Treated with T-DM1 in a Genentech-Sponsored T-DM1 Study Rugo
Study for Sample Acquisition for Patients Diagnosed with S. aureus Bacteremia Chambers
YV25718: A phase IIIb parallel group, open label study of pegylated interferon alfa-2a monotherapy (PEG-IFN, Ro 25-8310) compared to untreated control in children with HBeAg positive chronic hepatitis B Rosenthal
A Phase III, Open-Label, Randomized Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination with Bevacizumab versus Sunitinib in Patients with Untreated Advanced Renal Cell Carcinoma Fong
A Phase III, Multicentre, Randomized, Parallel-Group, Double Blinded, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis Waubant
Study of Paclitaxel eith GDC-0941 vs Paclicaxel with placebo in patients with locally recurrent or Metastatic Breast Cancer Melisko
A Phase III Study Of Lebrikizumab In Patients With Uncontrolled Asthma Who Are On Inhaled Corticosteriods And A Second Controller Medication Nahid
PNOC-002: Safety, Phase 0, and Pilot Efficacy Study of vemurafenib, an oral inhibitor of BRAFV600E, in Children with Recurrent/Refractory BRAFV600E-mutant gliomas Prados
A Phase II, Randomized, Double-Blind, Placebo Controlled Bronchoscopy Study to Evaluate the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Patients with Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication Woodruff